多参数流式细胞术评分整合可改善原发性骨髓纤维化标准模型的预后分层
该研究纳入363例初诊骨髓纤维化患者,用多参数流式细胞术测定外周血CD34+细胞计数并构建MFC评分,将患者分为MFC低、中、高三组,中位总生存期分别为未达到、55个月和19个月,将MFC参数替代形态学外周血原始细胞计数后,IPSS和MIPSS70+模型的C指数均提高。
要点
- MFC低、中、高三组中位OS分别为未达到、55个月和19个月。
- MFC增强IPSS模型C指数0.74,标准IPSS模型0.67(Z评分-3.82,p=0.0001)。
- MFC增强MIPSS70+模型C指数0.78,标准MIPSS70+模型0.73(Z评分-2.88,p=0.004)。
核心结论
- 纳入源自CD34+细胞计数标准检测的MFC参数,可能有助于完善骨髓纤维化当前的预后分层模型。
研究设计与样本
- 研究纳入363例初诊骨髓纤维化患者,均有可用于测定外周血CD34+细胞计数的多参数流式细胞术文件。
- 将Ogata评分适配于骨髓纤维化场景,纳入绝对CD34+细胞计数(/μL)和粒细胞与淋巴细胞SSC比值两个参数,每个参数高于阈值记1分。
- 按MFC评分将患者分为MFC低(0分,62.0%)、MFC中(1分,29.5%)和MFC高(2分,8.5%)三组。
- 将MFC参数替代形态学外周血原始细胞计数整合入现有模型,按MFC增强评分重新分类患者并比较一致性(C)指数。
主要发现
- MFC低组中位总生存期未达到,显著长于MFC中组55个月和MFC高组19个月。
- IPSS标准模型C指数0.67,MFC增强模型C指数0.74(Z评分-3.82;p=0.0001)。
- 原发性骨髓纤维化患者中,MFC增强MIPSS70+模型C指数0.78,优于标准MIPSS70+模型的0.73(Z评分-2.88,p=0.004)。
关键数值与推荐
- MFC评分:绝对CD34+细胞计数(/μL)和粒细胞与淋巴细胞SSC比值各高于阈值记1分,总分0分为MFC低、1分为MFC中、2分为MFC高。
- MFC低、中、高三组中位OS分别为未达到、55个月和19个月。
- IPSS标准模型C指数0.67,MFC增强模型0.74(Z评分-3.82;p=0.0001)。
- MIPSS70+标准模型C指数0.73,MFC增强模型0.78(Z评分-2.88,p=0.004)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prognostic modeling in myelofibrosis (MF) has classically pursued the integration of informative clinical and hematological parameters to separate patients' categories with different outcomes. Modern stratification includes also genetic data from karyotype and mutations. However, some poorly standardized variables, as peripheral blood (PB) blast count by morphology, are still included. In this study, we used multiparameter flow cytometry (MFC) with the aim of improving performance of existing scores. We studied 363 MF patients with available MFC files for PB CD34+ cells count determination at diagnosis. We adapted Ogata score to MF context including 2 parameters: absolute CD34+ cells count (/μL) and granulocytes to lymphocytes SSC ratio. A score of 1 was attributed to above-threshold values of each parameter. Accordingly, patients were categorized as MFClow (score = 0, 62.0%), MFCint (score = 1, 29.5%), and MFChigh (score = 2, 8.5%). MFClow had significantly longer median OS (not reached) compared to MFCint (55 months) and MFChigh (19 months). We integrated MFC into established models as a substitute of morphological PB blasts count. Patients were reclassified according to MFC-enhanced scores, and concordance (C-) indexes were compared. As regards IPSS, C-indexes were 0.67 and 0.74 for standard and MFC-enhanced model, respectively (Z score - 3.82; p = 0.0001). MFC-enhanced MIPSS70+ model in PMF patients yielded a C-index of 0.78, outperforming its standard counterpart (C-index 0.73; Z score - 2.88, p = 0.004). Our data suggest that the incorporation of MFC-derived parameters, easily attainable from standard assay used for CD34+ cells determination, might help to refine the current prognostic stratification models in myelofibrosis.
引用
- Mannelli F, Bencini S, Coltro G, et al. Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis. Am J Hematol. 2022. PMID: 35338671. doi:10.1002/ajh.26548
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。